VTI has support the global cosmetic market since 1996. Skincare, hair care, make-up, perfumes, toiletries and deodorants, and oral cosmetics are the main product categories of the cosmetic market. We support many of clients that have FDA warning letters and consent decrees.
Consumer Healthcare Products
VTI Life Science is leader in the validation of over-the-counter (OTC) medicines and dietary supplements. We have over 25 years of supporting large multinational companies with the commission and qualification of their facilities worldwide. On June 25, 2007, the U.S. Food and Drug Administration (FDA) released the final rule for dietary supplement Current Good Manufacturing Practices (cGMPs). This rule, which establishes uniform standards needed to ensure quality throughout the manufacturing, packaging, labeling, and holding of dietary supplement products, was implemented in 2008 for large companies and allowed for a three-year phase-in for smaller companies. Beginning in June 2010, all companies manufacturing, packaging, labeling, or holding dietary supplements were required to comply. This final rule requires that manufacturers verify the identity, purity, strength, and composition of their dietary supplement products. Dietary supplements containing contaminants or those not containing the dietary ingredient represented on the label would be considered adulterated or misbranded by FDA
OTC medicines, the Monograph System, has been in place since 1972. Although the system has worked well for many decades, it has currently ground to a halt, making it difficult for FDA and the regulated industry to reflect the most recent science on product labels and in innovations. The currently proposed reforms, supported by industry, FDA and many stakeholders, are reflected in legislation that has passed the House of Representatives, most recently in January 2019